The latest closing stock price for Protagonist Therapeutics as of November 20, 2024 is 40.65.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,474 today, roughly 2 times their original investment - a 16.84% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 20.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 16.80, which is 58.7% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 33.08.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $2,474 today, roughly 2 times their original investment - a 16.84% compound annual growth rate over 8 years.
The all-time high Protagonist Therapeutics stock closing price was 49.69 on September 01, 2021.
The Protagonist Therapeutics 52-week high stock price is 48.89, which is 20.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 16.80, which is 58.7% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 33.08.